{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:25:06Z","timestamp":1793294706034,"version":"4.5.0"},"reference-count":89,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/mark\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Tissue Barriers"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1080\/21688370.2023.2292461","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T09:41:39Z","timestamp":1702546899000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":74,"title":["Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer\u2019s and Parkinson\u2019s diseases"],"prefix":"10.1080","volume":"12","author":[{"given":"Elizabeth M.","family":"Rhea","sequence":"first","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]},{"name":"University of Washington School of Medicine","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Babin","sequence":"additional","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Thomas","sequence":"additional","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Omer","sequence":"additional","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Weaver","sequence":"additional","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Hansen","sequence":"additional","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Banks","sequence":"additional","affiliation":[{"name":"Geriatrics Research Education and Clinical Center","place":["Seattle, USA"]},{"name":"University of Washington School of Medicine","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Talbot","sequence":"additional","affiliation":[{"name":"Loma Linda University School of Medicine","place":["Loma Linda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_8_3_1","volume-title":"Lilly\u2019s donanemab significantly slowed cognitive and functional decline in phase 3 study of early Alzheimer\u2019s disease","author":"Lilly E.","year":"2023","unstructured":"Lilly E. Lilly\u2019s donanemab significantly slowed cognitive and functional decline in phase 3 study of early Alzheimer\u2019s disease. PR Newswire; 2023 [accessed 2023 May 3]. https:\/\/www.prnewswire.com\/news-releases\/lillys-donanemab-significantly-slowed-cognitive-and-functional-decline-in-phase-3-study-of-early-alzheimers-disease-301814001.html"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.5205"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207156"},{"key":"e_1_3_8_6_1","volume-title":"Additional deaths of patients taking aduhelm spark renewed concern","author":"Terry M","year":"2022","unstructured":"Terry M. Additional deaths of patients taking aduhelm spark renewed concern. Biospace; 2022 [accessed 2022 Feb 17]. https:\/\/www.biospace.com\/article\/additional-patient-deaths-in-patients-receiving-biogen-s-aducanumab\/#:~:text=Additional%20Deaths%20of%20Patients%20Taking%20Aduhelm%20Spark%20Renewed%20Concern,-Published%3A%20Feb%2017&text=The%20recent%20deaths%20associated%20with,died%20from%20a%20brain%20abnormality"},{"key":"e_1_3_8_7_1","volume-title":"Scientists tie third clinical trial death to experimental Alzheimer\u2019s drug","author":"Piller C","year":"2022","unstructured":"Piller C. Scientists tie third clinical trial death to experimental Alzheimer\u2019s drug. Science; 2022 [accessed 2022 Dec 21]. https:\/\/www.science.org\/content\/article\/scientists-tie-third-clinical-trial-death-experimental-alzheimer-s-drug"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-00030-3"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2215148"},{"key":"e_1_3_8_10_1","volume-title":"It\u2019s not a miracle drug: eli Lilly\u2019s antibody slows Alzheimer\u2019s disease but safety issues linger","author":"Travis J","year":"2023","unstructured":"Travis J. It\u2019s not a miracle drug: eli Lilly\u2019s antibody slows Alzheimer\u2019s disease but safety issues linger. Science; 2023 [accessed 2023 July 17]. https:\/\/www.nbcnews.com\/health\/health-news\/eli-lillys-alzheimers-drug-slows-memory-decline-study-finds-rcna94530"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158208"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173554"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14050458"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00061-2"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202867"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00279-2"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203395"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2016.12.005"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.560375"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12760"},{"key":"e_1_3_8_21_1","volume-title":"AD\/PD 2021 Virtual Conference","author":"Talbot K","year":"2021","unstructured":"Talbot K (2021) Direct demonstration of brain insulin resistance in Alzheimer\u2019s and Parkinson\u2019s disease dementia and its alleviation with incretin receptor agonists. AD\/PD 2021 Virtual Conference"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071582"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-179923"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59903"},{"key":"e_1_3_8_25_1","volume-title":"AD\/PD 2023 International Conference","author":"Talbot K","year":"2023","unstructured":"Talbot K, Wang H-Y (2023) Insulin resistance in the cerebral cortex of cognitively impaired Parkinson\u2019s disease (PD) cases is reduced by exenatide and the dual incretin receptor agonist DA4-JC. AD\/PD 2023 International Conference, Gothenburg, Sweden. abstract of poster P0848\/#1774"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189987"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.12.004"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00161"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1738383"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.970925"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0315-7"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.06.003"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1954"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep03754"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.10.006"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30231-3"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00788"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01792-4"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2022.955258"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020751"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1764534"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15502"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S348055"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2022122"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2022.2079492"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170184"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205016666190913155950"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.3068"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/1533317519899546"},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12268"},{"key":"e_1_3_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114187"},{"key":"e_1_3_8_52_1","article-title":"FDA Center for Drug Evaluation and Research, Application Number: 125431Orig1s000 (albiglutide)","author":"McGovern TJ","year":"2013","unstructured":"McGovern TJ FDA Center for Drug Evaluation and Research, Application Number: 125431Orig1s000 (albiglutide). Pharmacology Review(s). 2013 23. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/125431Orig1s000PharmR.pdf","journal-title":"Pharmacology Review(s)"},{"key":"e_1_3_8_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2016.1240780"},{"key":"e_1_3_8_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28683-0"},{"key":"e_1_3_8_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700781"},{"key":"e_1_3_8_56_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.10.2821"},{"key":"e_1_3_8_57_1","article-title":"FDA Center for Drug Evaluation and Research, Application Number: 125469Orig1s000 (dulaglutide)","volume":"16","author":"McGovern TJ","year":"2014","unstructured":"McGovern TJ. FDA Center for Drug Evaluation and Research, Application Number: 125469Orig1s000 (dulaglutide). Pharmacology Review(s). 2014;16. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/125469Orig1s000PharmR.pdf.","journal-title":"Pharmacology Review(s)"},{"key":"e_1_3_8_58_1","doi-asserted-by":"publisher","DOI":"10.4155\/cli.14.65"},{"key":"e_1_3_8_59_1","unstructured":"Markey GAW M. (2014) Assessment Report on Trulicity. European Medicines Agency\/Committee for Medicinal Products for Human Use\/Report 524604\/2014 22"},{"key":"e_1_3_8_60_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140532"},{"key":"e_1_3_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.09.009"},{"key":"e_1_3_8_62_1","volume-title":"FDA approves Lilly\u2019s Mounjaro\u2122 (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes","author":"Lilly E","year":"2022","unstructured":"Lilly E. FDA approves Lilly\u2019s Mounjaro\u2122 (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes. Cision PR Newswire; 2022 [accessed 2022 May 13]. https:\/\/www.prnewswire.com\/news-releases\/fda-approves-lillys-mounjaro-tirzepatide-injection-the-first-and-only-gip-and-glp-1-receptor-agonist-for-the-treatment-of-adults-with-type-2-diabetes-301547339.html."},{"key":"e_1_3_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.040"},{"key":"e_1_3_8_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902510209"},{"key":"e_1_3_8_65_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043384862"},{"key":"e_1_3_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.04.002"},{"key":"e_1_3_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)30016-9"},{"key":"e_1_3_8_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1983.1"},{"key":"e_1_3_8_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1983.2"},{"key":"e_1_3_8_70_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP276149"},{"key":"e_1_3_8_71_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1993.1059"},{"key":"e_1_3_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(95)00250-V"},{"key":"e_1_3_8_73_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007218"},{"key":"e_1_3_8_74_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133429"},{"key":"e_1_3_8_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-10324-7_2"},{"key":"e_1_3_8_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2023.123688"},{"key":"e_1_3_8_77_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041623"},{"key":"e_1_3_8_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/55.12.B601"},{"key":"e_1_3_8_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.09.007"},{"key":"e_1_3_8_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac309"},{"key":"e_1_3_8_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.11.026"},{"key":"e_1_3_8_82_1","first-page":"617","article-title":"On the stimulation by insulin of tryptophan transport across the blood-brain barrier","volume":"7","author":"Cangiano C","year":"1983","unstructured":"Cangiano C, Cardelli-Cangiano P, Cascino A, Patrizi MA, Barberini F, Rossi F, Capocaccia L, Strom R. On the stimulation by insulin of tryptophan transport across the blood-brain barrier. Biochem Int. 1983;7:617\u2013627.","journal-title":"Biochem Int"},{"key":"e_1_3_8_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(88)90433-0"},{"key":"e_1_3_8_84_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710625114"},{"key":"e_1_3_8_85_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1860-14.2014"},{"key":"e_1_3_8_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/1533317520953041"},{"key":"e_1_3_8_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(98)00018-7"},{"key":"e_1_3_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102"},{"key":"e_1_3_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.07.011"},{"key":"e_1_3_8_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101181"}],"updated-by":[{"DOI":"10.1080\/21688370.2026.2634592","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000}}],"container-title":["Tissue Barriers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21688370.2023.2292461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:58:12Z","timestamp":1773424692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21688370.2023.2292461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1080\/21688370.2023.2292461"],"URL":"https:\/\/doi.org\/10.1080\/21688370.2023.2292461","relation":{},"ISSN":["2168-8370"],"issn-type":[{"value":"2168-8370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ktib20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ktib20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2292461"}}